Skip to main content
. 2017 Apr-Jun;33(2):164–171. doi: 10.4103/joacp.JOACP_350_16

Table 4.

Usage pattern of neuromuscular blockers and reversal drug (full analysis set)

graphic file with name JOACP-33-164-g005.jpg